Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week biotech was front and center, with some of the industry’s top funds putting fresh capital to work.
Here’s the most notable activity:
Let’s start with Celcuity $CELC, where the Baker Bros stepped in with a $9.5 million purchase.
The Bakers are the gold standard in biotech investing — when they put money to work, it’s always worth paying attention.
Sticking with biotech, Summit Therapeutics $SMMT saw its Co-CEO buy nearly $6 million in stock. That’s a big show of confidence and it’s coming straight from the top.
Over at NovoCure $NVCR, the CEO added just under $1 million worth of shares.
It’s always notable when those running the company step up and add some extra skin in the game.
Broadcom $AVGO also showed up on our scan, with Director Harry You dropping $1.2 million into the semiconductor giant.
In software, Salesforce $CRM Director David Blair Kirk purchased roughly $865K worth of shares. Another bullish insider signal at one of the top players in tech.
And finally, Sotera Health $SHC.
Sculptor Capital LP disclosed a fresh 5.19% stake in the diagnostics and research firm — a new position that puts them right at the top of the shareholder register.
If you're not a member of Hot Corner Insider and want access to exclusive trade ideas, weekly conference calls, and deep dive reports, join us risk-free.
